Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy

Laboratory Investigation

Volumn 84, Issue 9, 2004, Pages 1112-1125

  Qiu, Lian Qun ^a   Sinniah, Raja ^b   Hsu, Stephen I H ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Apoptosis; Cell cycle regulatory protein; Glomerulosclerosis; IgA nephropathy; Mesangial cell proliferation

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLINE; MYC PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P57; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; NICK END LABELING; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IN SITU NICK-END LABELING; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; UP-REGULATION;

EID: 4344624072     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700144     Document Type: Article

References (49)

1. Shankland SJ. Cell cycle regulatory proteins in glomerular disease. Kidney Int 1999;56:1208-1215.
2. Shankland SJ, Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000;278:F515-F529.
3. Shankland SJ, Hugo C, Coats SR, et al. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 1996;50:1230-1239.
4. Terada Y, Inoshita S, Nakashima O, et al. Cyclins and the cyclin-kinase system-their potential roles in nephrology. Nephrol Dial Transplant 1998;13:1913-1916.
5. Schocklmann HO, Lang S, Sterzel RB. Regulation of mesangial cell proliferation. Kidney Int 1999;56:1199-1207.
6. Pippin JW, Qu Q, Meijer L, et al. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 1997;100:2512-2520.
7. Shankland SJ, Floege J, Thomas SE, et al. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 1997;52:404-413.
8. Schoecklmann HO, Rupprecht HD, Zauner I, et al. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Kidney Int 1997;51:1228-1236.
9. Shankland SJ, Pippin J, Flanagan M, et al. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int 1997;51:1088-1099.
10. Shankland SJ, Scholey JW, Ly H, et al. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 1994;46:430-442.
11. Berger J. IgA glomerular deposits in renal disease. Transplant Proc 1969;1:939-944.
12. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994;73:79-102.
13. Radford Jr MG, Donadio Jr JV, Bergstralh EJ, et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997;8:199-207.
14. Sinniah R, Javier AR, Ku G. The pathology of mesangial IgA nephritis with clinical correlation. Histopathology 1981;5:469-490.
15. Sinniah R, Pwee HS, Lim CH. Glomerular lesions in asymptomatic microscopic hematuria discovered on routine medical examination. Clin Nephrol 1976;5:216-228.
16. Qiu LQ, Sinniah R, Hsu I-Hong. Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. J Am Soc Nephrol 2004;15:79-90.
17. Rui-Mei L, Kara AU, Sinniah R. In situ analysis of adhesion molecule expression in kidneys infected with murine malaria. J Pathol 1998;185:219-225.
18. Khan TN, Sinniah R. Renal tubular antiproteinase (alpha-1-antitxypsin and alpha-1-antichymotxypsin) response in tubulo-interstitial damage. Nephron 1993;65:232-239.
19. Sinniah R, Churg J. Effect of IgA deposits on the glomerular mesangium in Berger's disease. Ultrastruct Pathol 1983;4:9-22.
20. To KF, Choi PC, Szeto CC, et al. Outcome of IgA nephropathy in adults graded by chronic histological lesions. Am J Kidney Dis 2000;35:392-400.
21. Soma J, Saito T, Seino J, et al. Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I. Clin Exp Immunol 1995;100:269-276.
22. Hotta O, Furuta T, Chiba S, et al. Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis 2002;39:493-502.
23. Nakopoulou L, Stefanaki K, Salpigidis K, et al. The value of proliferating cell nuclear antigen (PCNA)/cyclin in the assessment of cell proliferation in glomerulonephritis. Histol Histopathol 1997;12:655-662.
24. Yoshioka K, Takemura T, Akano N, et al. Cellular and non-cellular compositions of crescents in human glomerulonephritis. Kidney Int 1987;32:284-291.
25. Nagata M, Shu Y, Tomari S. Role of cell cycle molecules in the pathophysiology of glomerular epithelial cells. Microsc Res Techn 2002;57:203-207.
26. Mundle SD, Saberwal G. Evolving intricacies and implications of E2F1 regulation. FASEB J 2003;17:569-574.
27. Inoshita S, Terada Y, Nakashima O, et al. Regulation of the G1/S transition phase in mesangial cells by E2F1. Kidney Int 1999;56:1238-1241.
28. Ren B, Cam H, Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 2002;16:245-256.
29. Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001;15:267-285.
30. Inoshita S, Terada Y, Nakashima O, et al. Roles of E2F1 in mesangial cell proliferation in vitro. Kidney Int 1999;56:2085-2095.
31. Maeshima Y, Kashihara N, Yasuda T, et al. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest 1998;101:2589-2597.
32. Tomita N, Horiuchi M, Tomita S, et al. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am J Physiol 1998;275:F278-F284.
33. Tsuboi N, Yoshida H, Kawamura T, et al. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells. Kidney Int 2000;57:1581-1589.
34. Fujigaki Y, Sun DF, Fujimoto T, et al. Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats. Virchows Arch 2001;439:35-45.
35. Pabst R, Sterzel RB. Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 1983;24:626-631.
36. Barisoni L, Mokrzycki M, Sablay L, et al. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 2000;58:137-143.
37. Nagata M, Horita S, Shu Y, et al. Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab Invest 2000;80:869-880.
38. Wang S, Kim JH, Moon KC, et al. Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis. Am J Kidney Dis 2004;43:19-27.
39. Baker AJ, Mooney A, Hughes J, et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94:2105-2116.
40. Shimizu A, Masuda Y, Kitamura H, et al. Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 1996;74:941-951.
41. Thomas GL, Yang B, Wagner BE, et al. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 1998;13:2216-2226.
42. Tashiro K, Kodera S, Takahashi Y, et al. Detection of apoptotic cells in glomeruli of patients with IgA nephropathy. Nephron 1998;79:21-27.
43. Sugiyama H, Kashihara N, Makino H, et al. Apoptosis in glomerular sclerosis. Kidney Int 1996;49:103-111.
44. Haas CS, Schocklmann HO, Lang S, et al. Regulatory mechanism in glomerular mesangial cell proliferation. J Nephrol 1999;12:405-415.
45. Maeshima Y, Kashihara N, Sugiyama H, et al. Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation. J Am Soc Nephrol 1996;7:2219-2229.
46. Pesce CM, Striker LJ, Peten E, et al. Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 1991;65:601-605.
47. Wolf G, Ziyadeh FN, Zahner G, et al. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 1996;27:897-905.
48. Orth SR, Weinreich T, Bonisch S, et al. Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells. Exp Nephrol 1995;3:23-33.
49. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int 2000;77:S59-S66.